{ Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD...
-
Upload
ashlie-jenkins -
Category
Documents
-
view
219 -
download
0
description
Transcript of { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD...
![Page 1: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/1.jpg)
{
Practicalities of intesive insulin therapy to optimase diabetes control
Ewa Pańkowska MD, PhD Warsaw, Poland
![Page 2: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/2.jpg)
At least four injections per day At least four glucose
measurements per day.
Outcomes: Less microvascular complications More severe hypoglycemia events
Intensive Insulin Therapy
DCCT, NEJM, 1993
20 years ago…
![Page 3: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/3.jpg)
{as a first choice regime for persons
with type 1 diabetes
Flexible, Intensive Insulin TherapyFIIT
ISPAD recommendation,ADA recommendation,PDA recommendation
10 years ago…
![Page 4: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/4.jpg)
British Medical Journal; 2002;
Conclusion: Skills training promoting dietary freedom improved quality of life and
glycaemic control in people with type 1 diabetes without worsening hypoglycemia
![Page 5: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/5.jpg)
What FIIT means?
Tsukuda, K. DT&T, 2009
![Page 6: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/6.jpg)
{
The tools and the algorythmin FIIT
Multiple daily injection vs continuous subcutaneous insulin infusion
![Page 7: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/7.jpg)
1. There are a lot of evidences that CSII improves metabolic control (HbA1c) comparing to MDI method. Is that True or False?
2. Insulin pump therapy significantly decreases risk of severe hypoglycemia events. True or False?
questions:
![Page 8: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/8.jpg)
The comparison between MDI and CSII.Are there relevant differences
for metabolic control
![Page 9: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/9.jpg)
6.00 10.00 12.00 15.00 18.00 20.00 22.00 24.00 3.00 6.00 10.00 12.0060
80
100
120
140
160
180
MDI CSI
Time
glyc
emia
mg/
dl
Pańkowska, E, ADA 2011
00.10.20.30.40.50.60.70.80.9
11.1
P<0,05
P<0,05
Basal insulin IU/kg/d Total daily dose IU/kg/d
MDICSII
Parallel day – to – day study
![Page 10: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/10.jpg)
Mealtime insulin• Regular insulin• Rapid acting
analogue Basal insulin:
• NPH• Long acting analogue
Delivering insulin:• subcutaneous and
shots administartion
Mealtime insulin• Rapid acting analogue
Basal insulin: • Rapid acting analogue
Delivering insulin:• Subcutaneus and
continuous administartion
* NPH – Isophane insulin (intermediate-acting)
![Page 11: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/11.jpg)
Number of injection/month average: 120-150
Insulin depot in subcutaneous tissue
basal insulin dose - 20 IU
Logbook as a form of injected insulin dose registration
Number of injection/month average: 8-10
Insulin depot in subcutaneous tissue
Basal: 20 IU/day - 0,8 IU/h
Electronic memory as a form of delivered insulin dose registration
![Page 12: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/12.jpg)
Basal insulin Once or twice a
day Insulin dose
adaptation once or twice per day
If injected, cannot be revoked
Basal function: Insulin dose adaptation
every hour or every half an hour
Possibility of suspension of basal insulin administration
Possibility of keeping different basal insulin profile in electronic memory – Basal Profiles
Possibility of adaptation of basal insulin for current needs - Temporary basal rate
![Page 13: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/13.jpg)
Bolus function:• One shot of insulin (RI or
analogue) before the meal
• One meal – one shot of insulin
• One kind of insulin shooting
Correction insulin: combine with meal insulin in one injection
Bolus function: Three kinds of boluses:
Normal (for Carbohydrates) Extended (for Fat-protein) Multiwave (for Mixed)
Possibility of programming one meal bolus as a multi-bolus (before, during and after a meal)
Correction insulin: programmed separately
![Page 14: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/14.jpg)
The schema of insulin dosing in FIIT
Total daily dose
50% Meal insulin
15% lunch
20% dinner
50% Basal insulin
15% Breakfas
t
?
![Page 15: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/15.jpg)
Patient’s age Diabetes duration ( years) C-petid residual secretion BMI Concomitant disease and hormonal
therapy
The factors influence basal insulin dose
![Page 16: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/16.jpg)
Patient’s age and duration of diabetes
1 248 patients with T1DM on insulin pumps
![Page 17: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/17.jpg)
The Percentage of basal insulin
Age Average SD
Preschooler 34.09 15.93
Prepubertal 43.13 12.48
Pubertal 47.43 12.44
Danne T., Diabetologia, 2008
Age Average SD
Preschooler 20.9 9.2
Prepubertal 26.1 12.50
Pubertal 31.8 12.00
Pańkowska E.. Pediatric Diabetes, 2008
![Page 18: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/18.jpg)
Duration of diabetes and C-peptide residual secretion
C-peptide and percentage of basal insulin in TDD
![Page 19: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/19.jpg)
The basal to bolus proportion related to C-peptide
Pańkowska E., Pediatric Diabetes, 2008
* p<0,05
*
![Page 20: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/20.jpg)
Basal insulin patterns
![Page 21: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/21.jpg)
Basal insulin dose in children and adolescents
0
0.5
1
1.5
2
01:00 04:00 07:00 10:00 13:00 16:00 19:00 22:00
Insu
lin U
/Hr
preschooler 1-6 ys, 0,2-0,3j/g Prepubertal 7-12 ys , 0,4-0,5j/g
pubertal, 13-18 ys; 0,9-1,0 j/g
0
0.5
1
1.5
2
01:00 04:00 07:00 10:00 13:00 16:00 19:00 22:00
Insu
lin U
/Hr
0
0.5
1
1.5
2
01:00 04:00 07:00 10:00 13:00 16:00 19:00 22:00
Insu
lin U
/Hr
![Page 22: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/22.jpg)
5years old girl with diabetes from 2 years .Basal insulin 6-10% of TDD
15 years old girl with diabetes from 10 ys
Basal insulin 30-45%of TDD
![Page 23: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/23.jpg)
Anna , 7 years old Diabetes for second year of life5 years duration, c-peptide naiveAsthma bronchialeHb1c- 6,5% ( average)
Case report
![Page 24: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/24.jpg)
![Page 25: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/25.jpg)
Blood glucose and insulin applaying pl-insmadz.pdf
![Page 26: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/26.jpg)
Case report
14 years old boy, Diabetes duration 4 years, HbA1c 7,0%
![Page 27: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/27.jpg)
![Page 28: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/28.jpg)
The blood glucose profile and insulin applying Paweł.pdf
Temporal basal rate and sick days
![Page 29: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/29.jpg)
the proportion of basal to bolus insulin can be ranged from 10% to 60%
Meal daily plan are flexible in term of meal’s size, timing for breakfast, lunch and dinner and meal nutrients contains .
Dual wave boluses/multiwave are applied by patients in their daily care.
Basal rate is lower during a day than night hours,
Summary
![Page 30: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.](https://reader035.fdocuments.us/reader035/viewer/2022062401/5a4d1b7a7f8b9ab0599b8c8d/html5/thumbnails/30.jpg)
Tailoring insulin programming
in pump therapy is one of the
way in getting recommended
metabolic control.
Conclusion